FC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient buyer: near-term momentum is weakening (MACD histogram negative and expanding) and price is below/near the pivot (20.195) with downside risk toward 19.171/18.539 supports.", "Options positioning is cautious-to-bearish (put-heavy open interest), while fundamentals just printed a weak quarter (revenue down, losses widened).", "If you must act immediately, this is more of a \u201cwait/hold off\u201d than a chase\u2014better odds come on a clean reclaim of 20.20+ with improving momentum, or a controlled dip toward support (19.17\u201318.54)."]
["Trend/MAs: Bullish structure on moving averages (SMA_5 > SMA_20 > SMA_200) suggests the longer trend is still constructive.", "Momentum: MACD histogram -0.189 (below 0 and negatively expanding) = bearish momentum building short term.", "RSI: RSI_6 = 40.5 (neutral-to-weak; not oversold enough to scream \u201cbuy the dip\u201d).", "Key levels: Pivot 20.195. Resistance R1 21.218 (then R2 21.851). Support S1 19.171 (then S2 18.539). Current post-market 19.78 sits below pivot\u2014technically vulnerable until it reclaims ~20.20.", "Pattern-based short-horizon odds: ~60% chance of -1.03% next day; then +1.17% next week; +0.45% next month (mildly positive beyond the very near term).", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Hedge funds are buying (reported +180.11% increase in buying amount over last quarter) \u2014 supportive flow signal.", "Analyst remains constructive: Barrington reiterates Outperform and most recently raised PT to $25 (from $22), citing potential acceleration in growth/profitability in the back half of 2026.", "Longer-term technical structure still positive (stacked SMAs)."]
["No fresh news catalysts in the past week to trigger an immediate upside repricing.", "Short-term momentum deterioration (MACD negative and worsening) while price sits below pivot resistance (~20.20).", "Options open interest skew (put-heavy) implies cautious positioning.", "Insiders are neutral (no supportive insider-buying signal recently).", "No recent congress trading data available (no external \u201cinfluential buyer\u201d confirmation)."]
["Latest quarter: 2026/Q1.", "Revenue: 64.045M, down -7.30% YoY (top-line contraction).", "Net income: -3.289M, down -378.49% YoY (losses widened materially).", "EPS: -0.27, down -400.00% YoY (sharp profitability deterioration).", "Gross margin: 72.74%, down -0.80% YoY (slight margin compression).", "Overall: growth and profitability trends in the latest quarter are negative, which reduces the attractiveness of buying immediately without a clear technical turn."]
["2025-11-06: Barrington kept Outperform but cut PT to $22 from $27 after FY26 guidance came in below expectations; noted deferred revenue/conversion lag and looked to acceleration later (FY27).", "2026-01-20: Barrington raised PT back up to $25 from $22, reiterated Outperform; expects acceleration in growth/profitability starting 2H 2026.", "Wall Street pros: ongoing Outperform stance + higher PT implies confidence in a forward inflection.", "Wall Street cons: prior PT cut and commentary about timing/conversion lag highlight that near-term fundamentals may remain soft before the expected acceleration shows up in reported results."]
